Where it comes from

Made in
Pituitary corticotrophs
Sent out by
With ACTH, one for one; the corticotroph cuts little of it further
Acts on
  • Fat cells (weakly)

What it does

  • A carrier for beta-endorphin and beta-MSH, which other cells cut from it
  • Circulates with ACTH and rises in Addison’s disease, Nelson’s syndrome and ectopic ACTH secretion 1
  • It is the main POMC product in human blood from this end of the molecule, outnumbering beta-endorphin by between three and thirty-eight to one 2

In medicine

  • Once measured as a proxy for ACTH, and dropped: the old assays could not tell beta-lipotropin from the beta-endorphin cut out of it 2
  • Two-site assays that separate the two exist, and showed that much of what earlier studies reported as circulating beta-endorphin was beta-lipotropin 2

Beyond the body’s own use

  • There is no beta-lipotropin product and no trial of one; it is a precursor, and the pieces cut from it are what act
  • Its name came from fat-mobilising activity in animal tissue, and in people that effect is weak and has never been shown to matter, which remains the open question about it 3
  • It does matter as a measurement problem: any claim about blood beta-endorphin has to show the assay was not reading beta-lipotropin instead 2
  • Levels rise in chronic kidney failure, which suggests the kidney clears it, and no clinical use has been made of that 1

Sources

  1. Bertagna et al., Simultaneous assay of immunoreactive beta-lipotropin, gamma-lipotropin and beta-endorphin in plasma, Journal of Clinical Investigation 1981
  2. Gibson et al., Discrimination between beta-endorphin and beta-lipotrophin in human plasma, Clinical Endocrinology 1993
  3. Bicknell, The tissue-specific processing of pro-opiomelanocortin, Journal of Neuroendocrinology 2008

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.